Daniel Belkin-Holland, MD
Procedural Dermatology · New York, NYNPI 1598010761
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Merz North America, Inc. at 58.9% of the total. Reporting peaked in 2024 at $108,267 and has fallen 57.8% since, to $45,739 in 2025. Among procedural dermatology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $1132.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$123K
- Galderma Laboratories, L.p.$76K
- AbbVie$5K
- Galderma Research & Development, LLC$3K
- Novartis$281
- Johnson & Johnson$241
- plus $1K from 19 others
What the payments were for
- Consulting fees$121,45558%
- Speaking & faculty fees$71,91335%
- Travel & lodging$10,1385%
- Food & beverage$4,8872%
- Education$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 40 | $122,677 |
| Galderma Laboratories, L.p. | 27 | $75,771 |
| AbbVie(2 entities) | 39 | $5,196 |
| Galderma Research & Development, LLC | 1 | $2,900 |
| Novartis | 13 | $281 |
| Johnson & Johnson | 10 | $241 |
| Dermavant Sciences, Inc. | 5 | $216 |
| Sun Pharmaceutical Industries Inc. | 9 | $183 |
| Arcutis Biotherapeutics, Inc. | 7 | $162 |
| Amgen | 6 | $149 |
| LEO Pharma Inc. | 4 | $100 |
| Gilead | 1 | $97 |
| E.r. Squibb & Sons, L.L.C. | 3 | $97 |
| Journey Medical Corporation | 4 | $66 |
| Incyte Corporation | 2 | $54 |
| Mayne Pharma Commercial LLC | 2 | $37 |
| Sanofi | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Fidia Pharma USA Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
| Biofrontera Inc. | 1 | $20 |
| UCB, Inc. | 1 | $17 |
| Pfizer | 1 | $15 |
| Strata Skin Sciences, Inc. | 1 | $14 |
| Botanix SB Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$208,417 in reported general payments places this provider in the 90th percentile of 69 procedural dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 11 | $579 |
| Minoxidil | 12 | $244 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in New York
- Michelle HenryNew York$460K
- Jerry ShapiroNew York$414K
- Dendy EngelmanNew York$292K
- Evan RiederNew York$210K
- Ariel OstadNew York$36K
- Elizabeth HaleNew York$34K
- Heidi WaldorfNew York$29K
- Robert FinneyNew York$19K
- Shera AranoffNew York$8K
- Lisa RothmanNew York$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.